Advanced Filters
noise
Found 64,778 clinical trials
T Thomas Starch-Jensen, Professor

Pain After Removal of Mandibular Third Molars With or Without Advanced Platelet-rich Fibrin

Pain is the most common complication following surgical removal of an impacted mandibular third molar. Several risk factors may increase the intensity and duration of pain following removal of mandibular third molars. Acute postoperative pain can transcript into postoperative chronic pain without an explainable reason or a specific risk factor. …

18 years of age All Phase N/A
M Maria G D'Angelo, MD

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

Until twenty years ago physical exercise in muscular dystrophies was considered harmful to the muscle cells, inducing an acceleration of cell necrosis. In fact, it is now certain and validated that an active lifestyle and the practice of controlled and regular physical activity are to be considered therapeutic in neuromuscular …

18 years of age All Phase N/A
W Winsome Lam, PhD

Nurse Parental Support Using a Mobile App in Symptom Management for CMC

Parents of children with medical complexity (CMC) are suffering from high level of stress. These CMC get multisystem diseases, including severe neurologic conditions or cancer, resulting in potential premature death. They experience one or more physical and psychological symptoms at one time, which seriously affect their quality of life and …

2 - 18 years of age All Phase N/A
M Mark Scheperle, MD

Accelerated ART Initiation for PWHIV Who Are Out of Care

The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for …

18 years of age All Phase 4
J Jeffery Zonder, MD

A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma

This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: Trametinib Dabrafenib

18 years of age All Phase 1
A Anthony A Sochet, MD

Azithromycin for Critical Asthma - Pediatrics

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

3 - 17 years of age All Phase 2/3
I Ian WONG, Dr.

The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel minimally invasive drug delivery system for patients with peritoneal metastases (PM). It has been considered as a safe and feasible palliative treatment alternative proven by previous phase I studies. Currently available evidence on feasibility, efficacy and tolerability in Asian populations is limited. …

18 years of age All Phase 2
A Amanda Maxton, BSN, RN

A Study of Pitolisant in Patients With Prader-Willi Syndrome

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant in patients living with Prader-Willi syndrome. The primary objective of this study is to evaluate the efficacy of pitolisant in treating excessive daytime sleepiness (EDS) in patients ≥6 years of …

6 years of age All Phase 3
I In-Jin Jang, Doctor

A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

The study is a Phase I, randomized double-blind, placebo-controlled, single and multiple dosing, dose-escalation study of the oral administration of DDN-A-0101 in healthy adults and elderly subjects

19 - 75 years of age All Phase 1

Online Support 4 CHD Kids & Caregivers

This study will evaluate a virtual mental health parenting stepped-care intervention (I-InTERACT-North) to determine if the program works to improve positive parenting skills and child behaviour among families with children born with Congenital Heart Disease (CHD). Recruitment will target children ages 3-9 years old from SickKids. We will also evaluate …

3 - 9 years of age All Phase N/A

Simplify language using AI